Related Experiment Video
Updated: Apr 17, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Prion pathogenesis in the absence of NLRP3/ASC inflammasomes
Mario Nuvolone1, Silvia Sorce1, Petra Schwarz1
1Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
Abstract:
The accumulation of the scrapie prion protein PrPSc, a misfolded conformer of the cellular prion protein PrPC, is a crucial feature of prion diseases. In the central nervous system, this process is accompanied by conspicuous microglia activation. The NLRP3 inflammasome is a multi-molecular complex which can sense heterogeneous pathogen-associated molecular patterns and culminates in the activation of caspase 1 and release of IL 1β. The NLRP3 inflammasome was reported to be essential for IL 1β release after in vitro exposure to the amyloidogenic peptide PrP106-126 and to recombinant PrP fibrils. We therefore studied the role of the NLRP3 inflammasome in a mouse model of prion infection. Upon intracerebral inoculation with scrapie prions (strain RML), mice lacking NLRP3 (Nlrp3-/-) or the inflammasome adaptor protein ASC (Pycard-/-) succumbed to scrapie with attack rates and incubation times similar to wild-type mice, and developed the classic histologic and biochemical features of prion diseases. Genetic ablation of NLRP3 or ASC did not significantly impact on brain levels of IL 1β at the terminal stage of disease. Our results exclude a significant role for NLRP3 and ASC in prion pathogenesis and invalidate their claimed potential as therapeutic target against prion diseases.
Insights
The NLRP3 inflammasome is not essential for prion disease progression or pathology in mice. Genetic deletion of NLRP3 or ASC did not alter scrapie incubation times or IL-1β levels, challenging therapeutic targeting.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Prion diseases involve the accumulation of misfolded prion proteins (PrPSc) and microglia activation in the central nervous system.
- The NLRP3 inflammasome, crucial for IL-1β release, was previously implicated in prion-related inflammation in vitro.
- Its role in prion disease pathogenesis in vivo remained uninvestigated.
Purpose of the Study:
- To investigate the role of the NLRP3 inflammasome and its adaptor ASC in prion disease pathogenesis using a mouse model.
- To determine if NLRP3 inflammasome components are essential for disease progression and neuroinflammation.
Main Methods:
- Intracerebral inoculation of scrapie prions (strain RML) into wild-type, Nlrp3-/-, and Pycard-/- mice.
- Monitoring of scrapie attack rates and incubation times.
- Histological and biochemical analysis of brain tissue, including IL-1β quantification.
Main Results:
- Mice lacking NLRP3 or ASC exhibited similar scrapie susceptibility and incubation periods compared to wild-type controls.
- Genetic ablation of NLRP3 or ASC did not significantly affect the classic features of prion disease.
- Brain IL-1β levels at the terminal stage of disease were not significantly impacted by the absence of NLRP3 or ASC.
Conclusions:
- The NLRP3 inflammasome and ASC are not critical for prion disease pathogenesis in this mouse model.
- These findings suggest that NLRP3 and ASC are unlikely to be effective therapeutic targets for prion diseases.
- The study refutes the claimed in vitro findings regarding the essential role of NLRP3 in prion disease.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Inflammatory Bowel Disease III: Crohn's Disease
Export of Misfolded Proteins out of the ER
Parkinson Disease ll: Pathophysiology
Encephalitis ll: Pathophysiology
Regulation of the Unfolded Protein Response

